GMVDF (G Medical Innovations Holdings) Total Equity: $-4.57 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMVDF G Medical Innovations Holdings Ltd GMVDF
12 GF Score
Price $0.00
View Full Analysis

What is G Medical Innovations Holdings Total Equity?

G Medical Innovations Holdings GMVDF 12 Total Equity is $-4.57 Mil as of Dec. 2022. GuruFocus rates GMVDF with a GF Score™ of 12/100.

G Medical Innovations Holdings's total equity for the quarter that ended in Dec. 2022 was $-4.57 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

G Medical Innovations Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for G Medical Innovations Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G Medical Innovations Holdings Total Equity Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Equity
Get a 7-Day Free Trial -2.59 -9.88 -2.95 -2.81 -4.57

G Medical Innovations Holdings Semi-Annual Data
Sep16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.95 6.65 -2.81 -1.24 -4.57
GMVDF
12GF Score
G Medical Innovations Holdings Ltd GMVDF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G Medical Innovations Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

G Medical Innovations Holdings's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=4.825-9.396
=-4.57

G Medical Innovations Holdings's Total Equity for the quarter that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=4.825-9.396
=-4.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-4.57 Mil mean?
G Medical Innovations Holdings (GMVDF) has a Total Equity of $-4.57 Mil as of Dec. 2022. The total amount of equity as record on a company's balance sheet. View historical data for G Medical Innovations Holdings and its competitors.
Is G Medical Innovations Holdings' Total Equity too high?
G Medical Innovations Holdings' current Total Equity is $-4.57 Mil. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' Total Equity compare to WHSI and ISRG?
G Medical Innovations Holdings' Total Equity of $-4.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for G Medical Innovations Holdings and its competitors. G Medical Innovations Holdings's current Total Equity is $-4.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current Total Equity of $-4.57 Mil. The current Total Equity is $-4.57 Mil. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current Total Equity is $-4.57 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

G Medical Innovations Holdings Business Description

Address 5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score

Get the complete analysis for GMVDF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price